Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Biological Products
  • Cardiovascular Diseases
  • Myocardial Infarction

abstract

  • Findings from this observational study of patients with RA suggested that anti-TNF biologics may be associated with higher AMI risk compared with abatacept.

publication date

  • January 20, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1136/annrheumdis-2015-207870

PubMed ID

  • 26792814

Additional Document Info

start page

  • 1813

end page

  • 8